A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ACM / aclacinomycin A

[Related PubMed/MEDLINE]
Total Number of Papers: 47
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ACM  (>> Co-occurring Abbreviation)
Long Form:   aclacinomycin A
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles. SLNs
2015 Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis. AML, CI
2015 RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer. ---
2013 Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation. CML, MAPK
2008 Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folate-PEG linker. FR
2005 Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. FR, PEG
1998 Effect of aclacinomycin A on in vitro cultures of porcine lens epithelial cells. SCF
1994 Culture conditions modulate the effects of aclacinomycin A on growth, differentiation and apoptosis of HL60 cells. FCM, OM
1993 Enhancement of tumor cell killing in vitro by pre- and post-irradiation exposure to aclacinomycin A. ---
10  1992 Enhancement of radiation-induced cell killing and DNA double-strand breaks in a human tumor cell line using nanomolar concentrations of aclacinomycin A. ---
11  1989 Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration. ADR, CAR, THP-ADR
12  1989 Low concentrations of cytosine arabinoside, 6-thioguanine, actinomycin-D and aclacinomycin A stimulates the differentiation of normal human marrow myeloid progenitor cells. 6-Th, ActD
13  1989 Role of the aclacinomycin A--doxorubicin association in reversal of doxorubicin resistance in K562 tumour cells. DOX
14  1988 Multiple mechanisms for the inhibition of rRNA synthesis during HL-60 leukemia cell differentiation. DMSO, MCM
15  1988 Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A. ADM, DNR, FLC
16  1987 Clinical studies of aclacinomycin A (ACM). ---
17  1987 Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study. SEEOG
18  1987 [Our experience with combined intravesical instillation therapy of superficial bladder tumor using Aclacinomycin-A (ACM) and cytosine arabinoside (CA)]. CA
19  1986 Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs. 5-FU, G6PDH, LDH, MMC
20  1985 A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck. ---
21  1985 Sensitive enzyme immunoassay for the quantification of aclacinomycin A using beta-D-galactosidase as a label. EIA, MABA, MBA
22  1985 [A case of acute promyelocytic leukemia complicated with severe esophageal stenosis caused by aclacinomycin A]. ---
23  1984 Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells. DAU, DOX, TFP
24  1984 Immunosuppression as a desired pharmacological effect. PFC
25  1984 Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin. MCM
26  1984 Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia. ADM, AML, CR, DNR
27  1984 [Evaluation of aclacinomycin-A in head and neck cancer]. ---
28  1984 [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor]. ---
29  1983 Fate of aclacinomycin-A and its metabolites effect on cell growth and macromolecular synthesis. AKV, FLC
30  1983 Phase II trial of aclacinomycin A in acute leukemia and various solid tumors. ---
31  1983 Purification and characterization of aclacinomycin A and its metabolites from human urine. HPLC, TLC
32  1983 [Japanese-French cooperation in tumor pharmacotherapy: 1970-1990]. ALL, AML, NHL, THP
33  1983 [Therapeutic results with aclacinomycin A in recurring acute leukemias]. ---
34  1982 Effects of aclacinomycin-A on murine leukemia. L-CFU
35  1982 Immunological cross-reactivities of various anthracycline antibiotics against aclacinomycin A antisera. ---
36  1982 Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia. ALL, ANLL
37  1982 Plasma kinetics of aclacinomycin A and its major metabolites in man. ---
38  1982 Radioimmunoassay for aclacinomycin A. RIA
39  1982 [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]. ---
40  1982 [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia]. DNR
41  1982 [Clinical evaluation of combination chemotherapy of aclacinomycin A (ACM) and 5-fluorouracil (5-FU) for advanced carcinoma of gastrointestinal tract]. 5-FU
42  1981 Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule. ---
43  1981 High performance liquid chromatographic determination of aclacinomycin A and its related compounds. I. Normal phase HPLC for monitoring fermentation and purification processes. ---
44  1981 High performance liquid chromatographic determination of aclacinomycin a and its related compounds. II. Reverse phase HPLC determination of aclacinomycin A and its metabolites in biological fluids using fluorescence detection. ---
45  1980 Antitumor efficacies of aclacinomycin A by oral administration. ADM
46  1980 Treatment of refractory acute leukemia with aclacinomycin-A. ---
47  1979 Cellular accumulation and disposition of aclacinomycin A. ---